Embecta (EMBC) Expected to Announce Quarterly Earnings on Friday

Embecta (NASDAQ:EMBC) is anticipated to release its earnings data before the market opens on Friday, February 14th. Analysts expect Embecta to post earnings of $0.45 per share for the quarter. Embecta has set its FY 2025 guidance at 2.700-2.900 EPS.Investors that are interested in registering for the company’s conference call can do so using this link.

Embecta (NASDAQ:EMBC) last released its earnings results on Thursday, February 6th. The company reported $0.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.20. Embecta had a negative return on equity of 19.22% and a net margin of 5.25%. On average, analysts expect Embecta to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Embecta Trading Down 5.0 %

Shares of EMBC stock opened at $16.62 on Thursday. Embecta has a 12 month low of $9.93 and a 12 month high of $21.48. The stock has a market capitalization of $966.12 million, a P/E ratio of 16.62, a PEG ratio of 0.95 and a beta of 1.20. The firm’s 50 day moving average is $19.38 and its 200 day moving average is $16.57.

Embecta Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Friday, February 28th will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 3.61%. The ex-dividend date of this dividend is Friday, February 28th. Embecta’s dividend payout ratio (DPR) is presently 60.00%.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. BTIG Research upgraded Embecta from a “neutral” rating to a “buy” rating and set a $26.00 price objective on the stock in a research report on Wednesday, November 27th. Morgan Stanley raised shares of Embecta from an “underweight” rating to an “equal weight” rating and increased their price target for the company from $13.00 to $20.00 in a research report on Monday, December 2nd.

About Embecta

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.